Egyptian Drug Authority Warns Against Misleading Retatrutide Promotion

The Egyptian Drug Authority has warned about a misleading advertisement promoting a product called Retatrutide, which is not registered with the authority.

The warning followed the authority’s detection of promotional material containing misleading claims about the product.

The authority flagged both the claims made in the advertisement and the product’s unregistered status. The warning concerns a product being marketed under the Retatrutide name.

The available information did not specify the claims made in the promotion or identify those responsible for the advertisement.